Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3430064rdf:typepubmed:Citationlld:pubmed
pubmed-article:3430064lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:3430064lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3430064lifeskim:mentionsumls-concept:C0036536lld:lifeskim
pubmed-article:3430064lifeskim:mentionsumls-concept:C0036537lld:lifeskim
pubmed-article:3430064lifeskim:mentionsumls-concept:C0814997lld:lifeskim
pubmed-article:3430064lifeskim:mentionsumls-concept:C0023820lld:lifeskim
pubmed-article:3430064lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:3430064pubmed:issue11lld:pubmed
pubmed-article:3430064pubmed:dateCreated1988-3-2lld:pubmed
pubmed-article:3430064pubmed:abstractTextLipoprotein secretion by Caco-2 cells, a human intestinal cell line, was studied in cells grown on inserts containing a Millipore filter (0.45 micron), separating secretory products from the apical and basolateral membranes into separate chambers. Under these conditions, as observed by electron microscopy, the cells formed a monolayer of columnar epithelial cells with microvilli on the apical surface and tight junctions between cells. The electrical resistances of the cell monolayers were 250-500 ohms/cm2. Both 14C-labeled lipids and 35S-labeled proteins were used to assess lipoprotein secretion. After a 24-hr incubation with [14C]oleic acid, 60-80% of the secreted triglyceride (TG) was in the basolateral chamber; 40% of the TG was present in the d less than 1.006 g/ml (chylomicron + VLDL) fraction and 50% in the 1.006 less than d less than 1.063 g/ml (LDL) fraction. After a 4-hr incubation with [35S]methionine, apolipoproteins were found to be major secretory products with 75-100% secreted to the basolateral chamber. Apolipoproteins B-100, B-48, E, A-I, A-IV, and C-III were identified by immunoprecipitation. The d less than 1.006 g/ml fraction was found to contain all of the major apolipoproteins, while the LDL fraction contained primarily apoB-100 and apoE; the HDL (1.063 less than d less than 1.21 g/ml) fraction principally contained apoA-I and apoA-IV. Mn-heparin precipitated all of the [35S]methionine-labeled apoB-100 and B-48 and a majority of the other apolipoproteins, and 80% of the [14C]oleic acid-labeled triglyceride, but only 15% of the phospholipid, demonstrating that Caco-2 cells secrete triglyceride-rich lipoproteins containing apoB. Secretion of lipoproteins was dependent on the lipid content of the medium; prior incubation with lipoprotein-depleted serum specifically reduced the secretion of lipoproteins, while addition of both LDL and oleic acid to the medium maintained the level of apoB-100, B-48, and A-IV secretion to that observed in the control cultures.lld:pubmed
pubmed-article:3430064pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:languageenglld:pubmed
pubmed-article:3430064pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:citationSubsetIMlld:pubmed
pubmed-article:3430064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3430064pubmed:statusMEDLINElld:pubmed
pubmed-article:3430064pubmed:monthNovlld:pubmed
pubmed-article:3430064pubmed:issn0022-2275lld:pubmed
pubmed-article:3430064pubmed:authorpubmed-author:KaydenH JHJlld:pubmed
pubmed-article:3430064pubmed:authorpubmed-author:RindlerM JMJlld:pubmed
pubmed-article:3430064pubmed:authorpubmed-author:TraberM GMGlld:pubmed
pubmed-article:3430064pubmed:issnTypePrintlld:pubmed
pubmed-article:3430064pubmed:volume28lld:pubmed
pubmed-article:3430064pubmed:ownerNLMlld:pubmed
pubmed-article:3430064pubmed:authorsCompleteYlld:pubmed
pubmed-article:3430064pubmed:pagination1350-63lld:pubmed
pubmed-article:3430064pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:meshHeadingpubmed-meshheading:3430064-...lld:pubmed
pubmed-article:3430064pubmed:year1987lld:pubmed
pubmed-article:3430064pubmed:articleTitlePolarized secretion of newly synthesized lipoproteins by the Caco-2 human intestinal cell line.lld:pubmed
pubmed-article:3430064pubmed:affiliationDepartment of Medicine, New York University School of Medicine, NY 10016.lld:pubmed
pubmed-article:3430064pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3430064pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3430064pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3430064lld:pubmed